Dr. Joseph Drabick, MD
Claim this profilePenn State Cancer Institute
Studies Melanoma
Studies Skin Cancer
4 reported clinical trials
8 drugs studied
Area of expertise
1Melanoma
Stage IV
Stage III
BRAF positive
2Skin Cancer
Stage IV
Stage III
BRAF positive
Affiliated Hospitals
Clinical Trials Joseph Drabick, MD is currently running
Propranolol + Pembrolizumab
for Skin Cancer
This phase Ib/II trial studies the side effects and best dose of propranolol hydrochloride when given together with pembrolizumab and how well they work in treating patients with stage IIIC-IV melanoma that cannot be removed by surgery. Pembrolizumab is a monoclonal antibody that "takes the brakes off the immune system" and thus allows for anti-tumor immune responses. Propranolol hydrochloride is a beta adrenergic blocking agent that can enhance immune cell responses when under stress. Giving propranolol hydrochloride and pembrolizumab may work better in treating patients with melanoma.
Recruiting3 awards Phase 1 & 211 criteria
APG-115 + Pembrolizumab
for Skin Cancer
This study aims to assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of APG-115, an MDM2 inhibitor, either alone or in combination with pembrolizumab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with metastatic melanomas or advanced solid tumors. Our hypothesis is that restoration of the immune response concomitant to inhibition of the MDM2 pathway (which restores p53 functions) may promote cancer cell death, leading to effective anticancer therapy.
Recruiting1 award Phase 1 & 213 criteria
More about Joseph Drabick, MD
Clinical Trial Related6 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Joseph Drabick, MD has experience with
- Pembrolizumab
- Daromun
- Adjuvant Therapy
- Surgery
- Propranolol Hydrochloride
- APG-115
Breakdown of trials Joseph Drabick, MD has run
Melanoma
Skin Cancer
Cutaneous Melanoma
Peripheral Nerve Sheath Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joseph Drabick, MD specialize in?
Joseph Drabick, MD focuses on Melanoma and Skin Cancer. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.
Is Joseph Drabick, MD currently recruiting for clinical trials?
Yes, Joseph Drabick, MD is currently recruiting for 4 clinical trials in Hershey Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Joseph Drabick, MD has studied deeply?
Yes, Joseph Drabick, MD has studied treatments such as Pembrolizumab, Daromun, Adjuvant therapy.
What is the best way to schedule an appointment with Joseph Drabick, MD?
Apply for one of the trials that Joseph Drabick, MD is conducting.
What is the office address of Joseph Drabick, MD?
The office of Joseph Drabick, MD is located at: Penn State Cancer Institute, Hershey, Pennsylvania 17033 United States. This is the address for their practice at the Penn State Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.